Literature DB >> 1691497

On the nature of antibody combining sites: unusual structural features that may confer on these sites an enhanced capacity for binding ligands.

E A Padlan1.   

Abstract

A detailed analysis of the structural aspects of antibody-antigen interactions has been made possible by the availability of X-ray structures for three complexes of antilysozyme Fabs to lysozyme (reviewed by Davies et al.: J. Biol. Chem. 263:10541-10544, 1988.) Examination of the antigen-contacting residues in the three antilysozyme Fabs reveals the occurrence of a large number of aromatics, particularly tyrosines, and the absence of apolar, aliphatic residues. Calculation of the frequency of occurrence of the various amino acid types reveals that tyrosines are three times, and histidines and asparagines eight times, more likely to be found in the complementarity-determining regions than in the framework of the variable domains. Analysis of the solvent accessibility of the residues in Fvs (the modules containing variable domains of the light and heavy chains) of known three-dimensional structure indicates that tyrosines and tryptophans are more exposed when they occur in the complementarity-determining regions than when in the framework. Furthermore, many more of the asparagines in the complementarity-determining regions than in the framework are buried. These asparagines appear to have a structural role in that they hydrogen-bond through their side chains to other side chains and, even more so, to the protein backbone. The stabilizing effect of the asparagines, plus the rigidity of the framework, may serve to allow the greater exposure of the aromatic residues to solvent. In view of the greater potential contribution of aromatic side chains to the total binding energy, these results suggest that antibody combining sites have structural features that make them especially suited for interacting with ligands.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691497     DOI: 10.1002/prot.340070203

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  39 in total

1.  Antibody-detected folding: kinetics of surface epitope formation are distinct from other folding phases.

Authors:  C S Raman; R Jemmerson; B T Nall
Journal:  Protein Sci       Date:  2000-01       Impact factor: 6.725

2.  Measures of residue density in protein structures.

Authors:  F Baud; S Karlin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

3.  Electrostatic contributions to protein-protein interactions: fast energetic filters for docking and their physical basis.

Authors:  R Norel; F Sheinerman; D Petrey; B Honig
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

4.  Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2.

Authors:  J Tormo; E Stadler; T Skern; H Auer; O Kanzler; C Betzel; D Blaas; I Fita
Journal:  Protein Sci       Date:  1992-09       Impact factor: 6.725

5.  Steric and hydrophobic determinants of the solubilities of recombinant sickle cell hemoglobins.

Authors:  M T Bihoreau; V Baudin; M Marden; N Lacaze; B Bohn; J Kister; O Schaad; A Dumoulin; S J Edelstein; C Poyart
Journal:  Protein Sci       Date:  1992-01       Impact factor: 6.725

6.  Systematic mutation and thermodynamic analysis of central tyrosine pairs in polyspecific NKG2D receptor interactions.

Authors:  David J Culpepper; Michael K Maddox; Andrew B Caldwell; Benjamin J McFarland
Journal:  Mol Immunol       Date:  2010-11-12       Impact factor: 4.407

7.  Fluorescence spectroscopy of monoclonal antibodies produced against the fluorescyl hapten conjugated through the xanthene ring.

Authors:  P R Droupadi; T Nanavaty; C Smith; D D Johnson; M Adamczyk; D S Linthicum
Journal:  J Fluoresc       Date:  1995-09       Impact factor: 2.217

8.  Contribution of asparagine residues to the stabilization of a proteinaceous antigen-antibody complex, HyHEL-10-hen egg white lysozyme.

Authors:  Akiko Yokota; Kouhei Tsumoto; Mitsunori Shiroishi; Takeshi Nakanishi; Hidemasa Kondo; Izumi Kumagai
Journal:  J Biol Chem       Date:  2009-12-28       Impact factor: 5.157

9.  How do two unrelated antibodies, HyHEL-10 and F9.13.7, recognize the same epitope of hen egg-white lysozyme?

Authors:  Jaume Pons; Jennifer R Stratton; Jack F Kirsch
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

10.  Mechanisms of aggregate formation and carbohydrate excipient stabilization of lyophilized humanized monoclonal antibody formulations.

Authors:  James D Andya; Chung C Hsu; Steven J Shire
Journal:  AAPS PharmSci       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.